Regulatory review: Updates from FSSAI, Malaysia's NPRA, and HMOs approval in China

By Tingmin Koe

- Last updated on GMT

Nutra regulatory updates from FSSAI, Malaysia's NPRA, and China

Related tags Fssai India HMOs

In our monthly nutra regulatory round-up, we take a closer look at India's nutraceutical regulatory approach through an interview with a former director from Food Safety and Standards Authority of India (FSSAI), Malaysia's advisory on oral aloe vera consumption, and China's approval of human milk oligosaccharides (HMOs) for use in infant formulas.
‘Very much conservative’: How India’s regulatory approach can pose innovation problems – Ex-FSSAI director

India is taking a “very conservative” approach in its regulations of nutraceuticals, which can pose problems for brands and suppliers seeking to introduce innovative new products, says Pradip Chakraborty, a former director from FSSAI in our Nutrachampion podcast.

India did not have a set of regulations dedicated to nutraceuticals only until year 2016, which was revised last year.

Recounting the regulatory changes in the past seven years, Chakraborty said: ““I will say that the FSSAI is very much conservative. [For example], the RDA (recommended dietary allowance) is much lesser [than overseas], and they do not allow a lot of ingredients and products which are available in the overseas markets.”

‘Wrong decision?’ Indian regulator orders removal of health supplements containing SAMe​  

The Food Safety and Standards Authority of India (FSSAI) has ordered the removal of health supplements containing S-Adenosyl-L-Methionine (SAMe) off the shelves.

The ingredient is permitted for use in OTC drugs and prescription medicines but banned in other products.

The regulator has since issued a statement calling for e-commerce platforms to delist all health supplements, Food for Special Medical Purposes (FSMP), and Foods for Special Dietary Uses (FSDU) containing SAMe.

Malaysia issues advisory on oral aloe vera and links with adverse kidney reactions

Malaysia’s health ministry issued an advisory on oral aloe vera products and its alleged links with kidney-related adverse reactions.

Between February 2020 and August 2023, five cases of kidney-related adverse reactions that were “possibly linked”​ to the consumption of products containing aloe vera as a single active ingredient were received, said the National Pharmaceutical Regulatory Agency.

The adverse reactions included acute kidney injury, worsening of existing kidney problems, and an increased levels of creatinine and urea in the blood, which signals a loss of kidney function.

China HMOs approvals: Two MNCs and one local giant get the green light from regulators

Human milk oligosaccharides (HMOs) are permitted for use in China’s infant formula products, with IFF, dsm-firmenich, and local dairy giant Mengniu securing the first wave of approvals in early October.

All three companies received approvals for their 2'-fucosyllactose (2’-FL) ingredient, while dsm-firmenich received an additional approval for lacto-N-neotetraose (LNnT), another HMO component.

The approvals are closely watched as HMOs are seen as one of the latest trends in infant nutrition​, but China had been slower than other countries in allowing its use.

Philippines sugar tax: ‘Watered-down’ policy will lead to fewer health gains – new data

Philippines’ sugar tax will lead to health and economic improvements, but to a lesser extent that if it had been enacted in its original form, new data suggests.

Writing in The Lancet Regional Health – Western Pacific, ​researchers said that the currently enforced sweetened beverage tax policy was likely to result in substantial healthcare cost savings.

Yet, the overall health benefits will not be as significant as hoped, partly due to the effects of corporate lobbying.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Gencor Pacific Limited

Gencor Pacific Limited

Content provided by Gencor | 05-Oct-2023 | Product Brochure

In a recent clinical trial backing its ingredient Libifem® for improved muscle strength, power, endurance and body composition with a females-only popluation...

Related suppliers

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast